Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 05, 2021 08:42 ET | Source: BioSyent Inc.

FeraMAX(MD) est le 1er choix de supplément de fer recommandé par les pharmaciens et les médecins canadiens pour la sixième année consécutive

MISSISSAUGA, Ontario, 05 mai 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent », Bourse de croissance TSX : RX) a le plaisir d’annoncer que pour la sixième année consécutive, FeraMAXMD a été...
May 03, 2021 08:00 ET | Source: BioSyent Inc.

FeraMAX® Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year

MISSISSAUGA, Ontario, May 03, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that for the sixth consecutive year, FeraMAX® has been named the #1...
April 14, 2021 08:00 ET | Source: BioSyent Inc.

BioSyent to Present at 2021 Bloom Burton & Co. Healthcare Investor Conference

MISSISSAUGA, Ontario, April 14, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming Bloom Burton & Co....
March 19, 2021 17:33 ET | Source: BioSyent Inc.

BioSyent Announces Grant of Restricted Share Units

MISSISSAUGA, Ontario, March 19, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved a grant of 67,252 Restricted...
March 17, 2021 08:00 ET | Source: BioSyent Inc.

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2020

MISSISSAUGA, Ontario, March 17, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and twelve months ended December 31, 2020. Key...
March 11, 2021 08:00 ET | Source: BioSyent Inc.

BioSyent Schedules Q4 and Full Year 2020 Earnings Release for March 17, 2021

MISSISSAUGA, Ontario, March 11, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended...
December 16, 2020 09:30 ET | Source: BioSyent Inc.

BioSyent Launches Combogesic®, First-Ever Acetaminophen + Ibuprofen Combination Tablet in Canada Now Available

MISSISSAUGA, Ontario, Dec. 16, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has commenced the...
December 11, 2020 08:00 ET | Source: BioSyent Inc.

BioSyent Announces Renewal of Normal Course Issuer Bid

MISSISSAUGA, Ontario, Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the...
November 26, 2020 08:00 ET | Source: BioSyent Inc.

BioSyent Releases Financial Results for Third Quarter and First Nine Months of 2020

MISSISSAUGA, Ontario, Nov. 26, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and nine months ended September 30, 2020. Key...
November 17, 2020 08:00 ET | Source: BioSyent Inc.

BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020

MISSISSAUGA, Ontario, Nov. 17, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended...